BUTYLATED HYDROXYANISOLE

Unresolved Excipient

Suggest One No specific molecular structure known for this excipient.
CAS
25013165
UNII
REK4960K2U
SYNONYMS
ZINC ID(s)
Availability
Present in 0 ZINC catalogs

Known Active Genes

There has not been any activity reported at 10μM or less for this excipient (per ChEBML)

Clinical Trials

This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).

(Browse) Purchasable Analogs in ZINC

Analogs cannot be located as there is no structure provided for this compound. Try a search by name.

Dosages

Route Formulation Per Unit Dose
Intramuscular Injection 0.03%
Iv(infusion) Injection 0.002%
Iv(infusion) Powder, For Injection Solution
Nasal Solution 2%
Nasal Spray, Metered 0.0002%
Oral Capsule 0.2MG
Oral Capsule, Gelatin Coated 0.07MG
Oral Capsule, Soft Gelatin 1MG
Oral Concentrate 0.01%
Oral Emulsion
Oral Granule, For Suspension
Oral Solution 0.02%
Oral Suspension 0.05%
Oral Tablet 0.4MG
Oral Tablet, Extended Release 0.5MG
Oral Tablet, Film Coated 0.4MG
Oral Tablet, Orally Disintegrating 0.42MG
Rectal Suppository 0.21MG
Sublingual Tablet 0.5MG
Topical Emulsion, Cream 5.2%
Topical Gel 0.05%
Topical Lotion
Topical Ointment 0.01%
Topical Solution
Topical Suppository
Vaginal Emulsion, Cream 0.13%
Vaginal Ointment 0.02%
Vaginal Suppository 1MG

More Information

Usage Over Time

Comments